Ischaemic Heart Diseases Clinical Trial
Official title:
The Effect of Ischaemic-Reperfusion in Man - A Bradykinin Dependent Pathway
Heart attacks are usually caused by a blood clot blocking an artery supplying blood to the heart. Current treatments are designed to relieve this blockage as quickly as possible to minimize damage to the heart muscle. However in restoring the supply of blood local damage known as "ischaemia-reperfusion injury" may occur. The aim of this study is to assess how clot forming and clot dissolving pathways are affected during this process, and examine the role of a natural inflammatory hormone, bradykinin. This will help the investigators to understand the mechanism by which ischaemia-reperfusion injury may occur and to devise new treatments for heart attacks.
n/a
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00789243 -
The Effect of Ischaemic-Reperfusion and Ischaemic Preconditioning on the Endogenous Fibrinolysis in Man
|
N/A | |
| Recruiting |
NCT03766529 -
Loop Isolation-based Uploading Pre-conditioning
|
||
| Completed |
NCT00351260 -
BBC ONE - British Bifurcation Coronary Study
|
Phase 3 | |
| Completed |
NCT00965393 -
The Effect of Ischaemic-Reperfusion and Remote Ischaemic Preconditioning in Man - A Bradykinin Dependent Pathway
|
N/A | |
| Completed |
NCT00789451 -
The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man
|
N/A |